Combined porcine transmissible gastroenteritis and porcine epizootic diarrhea living vaccine cryoprotectant and combined living vaccine

A technology for porcine epidemic diarrhea and freeze-dried protective agent, which is used in vaccines, freeze-dried transportation, veterinary vaccines, etc., can solve the problems of slow dissolving speed of freeze-dried products, depressions on the surface, loss of titer, etc., and reduce the drug price. loss, smooth surface, improved protective effect

Active Publication Date: 2020-02-18
SICHUAN HUASHEN ANIMAL BIOLOGICAL PRODS
View PDF10 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Aiming at the above-mentioned problems existing in the prior art, the present invention provides a lyoprotectant for porcine transmissible gastroenteritis and porcine epidemic diarrhea dual live vaccine and a dual live

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Combined porcine transmissible gastroenteritis and porcine epizootic diarrhea living vaccine cryoprotectant and combined living vaccine
  • Combined porcine transmissible gastroenteritis and porcine epizootic diarrhea living vaccine cryoprotectant and combined living vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] A freeze-dried protective agent for porcine transmissible gastroenteritis and porcine epidemic diarrhea dual live vaccine, which is composed of the following components in mass and volume percentages: 20% sucrose, 6% gelatin, 2% tryptone, 1% yeast extract powder, Chondroitin sulfate 0.1% and inositol 1%, the balance is water for injection.

[0018] A dual live vaccine, comprising a mixed virus liquid containing porcine transmissible gastroenteritis virus and porcine epidemic diarrhea virus and the above-mentioned porcine transmissible gastroenteritis, porcine epidemic diarrhea dual live vaccine lyoprotectant, wherein, The volume ratio of the mixed virus solution to the lyoprotectant is 4:1.

[0019] The preparation process of the above-mentioned dual live vaccine is as follows: (1) mixing and dissolving each component in the lyoprotectant, and then performing sterilization treatment; (2) mixing porcine transmissible gastroenteritis virus and porcine epidemic diarrhea vi...

Embodiment 2

[0021] A freeze-dried protective agent for porcine transmissible gastroenteritis and porcine epidemic diarrhea dual live vaccine, which consists of the following components in mass and volume percentages: 28% sucrose, 10% gelatin, 6% tryptone, 3% yeast extract powder, Chondroitin sulfate 2% and inositol 5%, the balance is water for injection.

[0022] A dual live vaccine, comprising a mixed virus liquid containing porcine transmissible gastroenteritis virus and porcine epidemic diarrhea virus and the above-mentioned porcine transmissible gastroenteritis, porcine epidemic diarrhea dual live vaccine lyoprotectant, wherein, The volume ratio of the mixed virus solution to the lyoprotectant is 8:1.

[0023] The preparation process of the above-mentioned dual live vaccine is as follows: (1) mixing and dissolving each component in the lyoprotectant, and then performing sterilization treatment; (2) mixing porcine transmissible gastroenteritis virus and porcine epidemic diarrhea virus ...

Embodiment 3

[0025] A freeze-dried protective agent for porcine transmissible gastroenteritis and porcine epidemic diarrhea dual live vaccine, which is composed of the following components in mass and volume percentages: 24% sucrose, 8% gelatin, 4% tryptone, 2% yeast extract powder, Chondroitin sulfate 1.5% and inositol 3%, the balance is water for injection.

[0026] A dual live vaccine, comprising a mixed virus liquid containing porcine transmissible gastroenteritis virus and porcine epidemic diarrhea virus and the above-mentioned porcine transmissible gastroenteritis, porcine epidemic diarrhea dual live vaccine lyoprotectant, wherein, The volume ratio of the mixed virus solution to the lyoprotectant is 7:1.

[0027] The preparation process of the above-mentioned dual live vaccine is as follows: (1) mixing and dissolving each component in the lyoprotectant, and then performing sterilization treatment; (2) mixing porcine transmissible gastroenteritis virus and porcine epidemic diarrhea vi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a combined porcine transmissible gastroenteritis and porcine epizootic diarrhea living vaccine cryoprotectant and a combined living vaccine. The cryoprotectant is prepared fromthe following components in percentage by mass volume: 20-28 percent of cane sugar, 6-10 percent of gelatin, 2-6 percent of tryptone, 1-3 percent of yeast extract powder, 0.1-2 percent of chondroitinsulfate, 1-5 percent of inositol and the balance being injection water, based on the unit of mass volume ratio being g/ml. The combined living vaccine comprises the cryoprotectant, the cryoprotectantcan effectively solve the problem that the surface of an existing lyophilized product has pits and cracks, and the lyophilized product has low dissolving speed and titer loss after lyophilization.

Description

technical field [0001] The invention belongs to the field of biopharmaceuticals, and in particular relates to a freeze-drying protectant for a dual live vaccine against porcine transmissible gastroenteritis and porcine epidemic diarrhea and the dual live vaccine. Background technique [0002] Freeze-dried vaccines are mainly composed of antigens and freeze-dried protective agents. Antigens can include proteins, viruses, bacteria, etc. At present, the market application of veterinary freeze-dried vaccines is relatively common. Although freeze-dried vaccines have the advantages of convenient storage and centralized mass production, there are still some problems in the freeze-drying process or freeze-drying effect, which restricts the development of freeze-dried vaccines. The inactivation of virus particles or bacteria during antigen preservation and vaccine freeze-drying is one of the important factors restricting the quality of vaccines. [0003] In order to maintain the im...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/19A61K47/26A61K47/42A61K47/46A61K47/10A61K39/295A61K39/225A61K39/215A61P31/14A61P1/12
CPCA61K9/19A61K39/12A61K47/10A61K47/26A61K47/42A61K47/46A61K2039/552A61K2039/70A61P1/12A61P31/14C12N2770/20034
Inventor 张传明肖昌建邝声耀阴文奇周远成郭沛王子健
Owner SICHUAN HUASHEN ANIMAL BIOLOGICAL PRODS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap